NGM Biopharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Roper Technologies $1.25 billion acquisition of Syntellis Performance Solutions
We advised Roper Technologies on the acquisition
Campbell Soup $2.7 billion acquisition of Sovos Brands
We are advising Campbell Soup on the acquisition
Virgin Orbit chapter 11 plan confirmed
We advised Virgin Investments as DIP lender, prepetition lender and equityholder in connection with the restructuring
British American Tobacco $5 billion notes offering and cash tender offer
The offering is composed of five tranches of notes
Allurion Technologies merger with Compute Health Acquisition
We advised the capital markets adviser on the de-SPAC transaction
Penske Truck Leasing $1.1 billion notes offering
The investment-grade senior notes are due 2028
Francisco Partners and TPG $6.5 billion acquisition of New Relic
We are advising Francisco Partners and TPG on the acquisition
Banc of California merger with PacWest and $400 million equity raise
We are advising JPMorgan as financial adviser and placement agent to Banc of California
Immedica Pharma acquisition of pegzilarginase assets from Aeglea
We advised Immedica on the transaction